EP1513864A4 - Polypeptides therapeutiques, acides nucleiques codant ces derniers et leurs procedes d'utilisation - Google Patents

Polypeptides therapeutiques, acides nucleiques codant ces derniers et leurs procedes d'utilisation

Info

Publication number
EP1513864A4
EP1513864A4 EP03710863A EP03710863A EP1513864A4 EP 1513864 A4 EP1513864 A4 EP 1513864A4 EP 03710863 A EP03710863 A EP 03710863A EP 03710863 A EP03710863 A EP 03710863A EP 1513864 A4 EP1513864 A4 EP 1513864A4
Authority
EP
European Patent Office
Prior art keywords
methods
nucleic acids
acids encoding
encoding same
therapeutic polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03710863A
Other languages
German (de)
English (en)
Other versions
EP1513864A2 (fr
Inventor
David W Anderson
Catherine E Burgess
Stacie J Casman
Linda Gorman
Weizhen Ji
Ramesh Kekuda
Li Li
Muralidhara Padigaru
Meera Patturajan
Carol E A Pena
Suresh G Shenoy
Richard A Shimkets
David J Stone
Raymond J Taupier Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CuraGen Corp
Original Assignee
CuraGen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/074,978 external-priority patent/US20040010119A1/en
Priority claimed from US10/138,588 external-priority patent/US20040018594A1/en
Application filed by CuraGen Corp filed Critical CuraGen Corp
Publication of EP1513864A2 publication Critical patent/EP1513864A2/fr
Publication of EP1513864A4 publication Critical patent/EP1513864A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Psychology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
EP03710863A 2002-02-08 2003-02-03 Polypeptides therapeutiques, acides nucleiques codant ces derniers et leurs procedes d'utilisation Withdrawn EP1513864A4 (fr)

Applications Claiming Priority (25)

Application Number Priority Date Filing Date Title
US74978 1987-07-17
US138588 1998-08-21
US35509902P 2002-02-08 2002-02-08
US355099P 2002-02-08
US35642402P 2002-02-12 2002-02-12
US10/074,978 US20040010119A1 (en) 2001-02-12 2002-02-12 Novel proteins and nucleic acids encoding same
US356424P 2002-02-12
US35792802P 2002-02-19 2002-02-19
US357928P 2002-02-19
US35860802P 2002-02-21 2002-02-21
US358608P 2002-02-21
US35986002P 2002-02-27 2002-02-27
US359860P 2002-02-27
US37557902P 2002-04-25 2002-04-25
US375579P 2002-04-25
US10/138,588 US20040018594A1 (en) 2001-05-03 2002-05-01 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
US38166602P 2002-05-17 2002-05-17
US381666P 2002-05-17
US38700202P 2002-06-07 2002-06-07
US387002P 2002-06-07
US39326502P 2002-07-02 2002-07-02
US393265P 2002-07-02
US40182502P 2002-08-07 2002-08-07
US401825P 2002-08-07
PCT/US2003/003403 WO2003066881A2 (fr) 2002-02-08 2003-02-03 Polypeptides therapeutiques, acides nucleiques codant ces derniers et leurs procedes d'utilisation

Publications (2)

Publication Number Publication Date
EP1513864A2 EP1513864A2 (fr) 2005-03-16
EP1513864A4 true EP1513864A4 (fr) 2006-04-05

Family

ID=27739575

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03710863A Withdrawn EP1513864A4 (fr) 2002-02-08 2003-02-03 Polypeptides therapeutiques, acides nucleiques codant ces derniers et leurs procedes d'utilisation

Country Status (4)

Country Link
EP (1) EP1513864A4 (fr)
JP (1) JP2005518200A (fr)
AU (1) AU2003215010A1 (fr)
WO (1) WO2003066881A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005012344A1 (fr) * 2003-08-01 2005-02-10 Zymogenetics, Inc. Proteine zacrp11 liee au complement d'adipocyte

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000005374A2 (fr) * 1998-07-22 2000-02-03 Incyte Pharmaceuticals, Inc. Molecules associees a une proliferation cellulaire
WO2001029217A2 (fr) * 1999-10-15 2001-04-26 Curagen Corporation Polypeptides, et polynucleotides codant ces polypeptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999014241A2 (fr) * 1997-09-17 1999-03-25 Genentech, Inc. Traitement d'affections liees aux fonctions immunitaires et compositions correspondantes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000005374A2 (fr) * 1998-07-22 2000-02-03 Incyte Pharmaceuticals, Inc. Molecules associees a une proliferation cellulaire
WO2001029217A2 (fr) * 1999-10-15 2001-04-26 Curagen Corporation Polypeptides, et polynucleotides codant ces polypeptides

Also Published As

Publication number Publication date
EP1513864A2 (fr) 2005-03-16
WO2003066881A2 (fr) 2003-08-14
AU2003215010A1 (en) 2003-09-02
WO2003066881A3 (fr) 2005-01-20
JP2005518200A (ja) 2005-06-23

Similar Documents

Publication Publication Date Title
WO2003023008A8 (fr) Polypeptides therapeutiques, acides nucleiques les codant, et modalites d'emploi correspondantes
EP1576169A4 (fr) Polypeptides therapeutiques, acides nucleiques codant pour ceux-ci et methodes d'utilisation associees
AU2003226416A8 (en) Polypeptides having xyloglucanase activity and nucleic acids encoding same
EP1487864A4 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et methodes d'utilisation associees
AU2002356534A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2003217956A8 (en) Therapeutic polypeptides, nucleic acids encoding same and methods of use
EP1446419A4 (fr) Polypeptides therapeutiques, acides nucleiques codant ceux-ci et procedes d'utilisation
EP1432726A4 (fr) Polypeptides therapeutiques, acides nucleiques codant ces derniers et methodes d'utilisation correspondantes
EP1401858A4 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation
EP1695078A4 (fr) Polypeptides de metadherine codant des acides nucleiques et procedes d'utilisation
EP1539985A4 (fr) Polypeptides therapeutiques, acides nucleiques encodant ces polypeptides, et procedes d'utilisation
EP1532238A4 (fr) Polypeptides therapeutiques, acides nucleiques les codant et procedes d'utilisation correspondant
EP1549671A4 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et methodes d'utilisation associees
EP1443913A4 (fr) Polypeptides therapeutiques, acides nucleiques encodant ces polypeptides et leurs procedes d'utilisation
EP1399537A4 (fr) Polypeptides therapeutiques, acides nucleiques les codant, et procedes d'utilisation
AU2003247537A8 (en) Chd5 encoding nucleic acids, polypeptides, antibodies and methods of use thereof
AU2003297399A8 (en) Nucleic acids encoding antifungal drug targets and methods of use
AU2003304034A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2003270424A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003060149A9 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation
AU2002365216A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1539807A4 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et leurs procedes d'utilisation
EP1513864A4 (fr) Polypeptides therapeutiques, acides nucleiques codant ces derniers et leurs procedes d'utilisation
AU4157002A (en) Novel human proteins, polynucleotides encoding them and methods of using the same
AU2003219743A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040901

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: CURAGEN CORPORATION

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12N 15/12 B

Ipc: 7C 07K 14/47 A

A4 Supplementary search report drawn up and despatched

Effective date: 20060220

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060525